Three experts resign as FDA advisors over approval of Alzheimer’s drug
Published
One former advisor accused the FDA of presenting “slanted” questions to committee.
Full ArticlePublished
One former advisor accused the FDA of presenting “slanted” questions to committee.
Full ArticleThree experts resigned in protest. Watchdog says it's FDA brass that should leave.